HM
ARWR icon

HealthCor Management’s Arrowhead Research ARWR Stock Holding History

HealthCor Management’s Portfolio ARWR Stock Details ARWR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-450,000
Closed -$7.39M – 54
2014
Q1 		$7.39M Buy
+450,000
New +$7.9M 0.44% 42

Other funds holding ARWR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HealthCor Management's ARWR Position: Q2 2014 in Review

HealthCor Management sold out of Arrowhead Research (ARWR) in Q2 2014, closing a stake of 450,000 shares — an estimated $7.39M sold.

HealthCor Management first reported a position in ARWR in Q1 2014 and held it in 1 quarter. The position peaked at $7.39M in Q1 2014. 112 funds tracked by Wall St. Rank hold ARWR as of Q2 2014.

  • HealthCor Management reported no remaining Arrowhead Research position as of Q2 2014 after selling out during the quarter.
  • HealthCor Management sold 450,000 Arrowhead Research shares in Q2 2014, an estimated $7.39M.
  • HealthCor Management first reported a position in Arrowhead Research in Q1 2014 and held it in 1 quarter.
  • HealthCor Management's Arrowhead Research position peaked at $7.39M in Q1 2014.
  • 112 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2014.

Based on HealthCor Management's 13F filing for Q2 2014, filed 14 Aug 2014.